PAX2
paired box 2 | PAX-2

PAX2 encodes paired box gene 2, one of many human homologues of the Drosophila melanogaster gene prd. The central feature of this transcription factor gene family is the conserved DNA-binding paired box domain. PAX2 is believed to be a target of transcriptional supression by the tumor suppressor gene WT1. Mutations within PAX2 have been shown to result in optic nerve colobomas and renal hypoplasia. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Dec 2014]

Member of: DE-2 DE-2.21
Biological processes 84 terms
DNA binding (GO:0003677)DNA binding (GO:0003677)DNA binding (GO:0003677)DNA binding (GO:0003677)DNA-binding transcription factor activity (GO:0003700)DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981)DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981)RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978)axonogenesis (GO:0007409)brain morphogenesis (GO:0048854)branching involved in ureteric bud morphogenesis (GO:0001658)branching involved in ureteric bud morphogenesis (GO:0001658)camera-type eye development (GO:0043010)cell differentiation (GO:0030154)cell fate determination (GO:0001709)cellular response to glucose stimulus (GO:0071333)cellular response to retinoic acid (GO:0071300)centriolar satellite (GO:0034451)chromatin (GO:0000785)cis-regulatory region sequence-specific DNA binding (GO:0000987)cochlea development (GO:0090102)cochlea morphogenesis (GO:0090103)glial cell differentiation (GO:0010001)inner ear morphogenesis (GO:0042472)mesenchymal to epithelial transition (GO:0060231)mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337)mesodermal cell fate specification (GO:0007501)mesonephros development (GO:0001823)metanephric collecting duct development (GO:0072205)metanephric distal convoluted tubule development (GO:0072221)metanephric epithelium development (GO:0072207)metanephric mesenchymal cell differentiation (GO:0072162)metanephric mesenchyme development (GO:0072075)metanephric nephron tubule formation (GO:0072289)metanephros development (GO:0001656)microtubule organizing center (GO:0005815)negative regulation of DNA-templated transcription (GO:0045892)negative regulation of apoptotic process (GO:0043066)negative regulation of apoptotic process (GO:0043066)negative regulation of programmed cell death (GO:0043069)negative regulation of reactive oxygen species metabolic process (GO:2000378)nephric duct formation (GO:0072179)nervous system development (GO:0007399)neural tube closure (GO:0001843)nucleoplasm (GO:0005654)nucleus (GO:0005634)nucleus (GO:0005634)nucleus (GO:0005634)optic chiasma development (GO:0061360)optic cup morphogenesis involved in camera-type eye development (GO:0002072)optic nerve development (GO:0021554)optic nerve morphogenesis (GO:0021631)optic nerve structural organization (GO:0021633)positive regulation of DNA-templated transcription (GO:0045893)positive regulation of DNA-templated transcription (GO:0045893)positive regulation of DNA-templated transcription (GO:0045893)positive regulation of epithelial cell proliferation (GO:0050679)positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0072108)positive regulation of metanephric DCT cell differentiation (GO:2000594)positive regulation of metanephric glomerulus development (GO:0072300)positive regulation of optic nerve formation (GO:2000597)positive regulation of transcription by RNA polymerase II (GO:0045944)positive regulation of transcription by RNA polymerase II (GO:0045944)pronephric field specification (GO:0039003)pronephros development (GO:0048793)protein binding (GO:0005515)protein-DNA complex (GO:0032993)protein-containing complex (GO:0032991)regulation of DNA-templated transcription (GO:0006355)regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307)regulation of metanephros size (GO:0035566)regulation of transcription by RNA polymerase II (GO:0006357)retinal pigment epithelium development (GO:0003406)sensory organ development (GO:0007423)sequence-specific double-stranded DNA binding (GO:1990837)stem cell differentiation (GO:0048863)system development (GO:0048731)transcription cis-regulatory region binding (GO:0000976)transcription factor binding (GO:0008134)ureter development (GO:0072189)ureter maturation (GO:0035799)urogenital system development (GO:0001655)vestibulocochlear nerve formation (GO:0021650)visual perception (GO:0007601)
Expression (TPM)
PAX2 — as a Regulated Gene

TFs regulating PAX2 0 TFs

Transcription factors with Perturb-seq knockdown data for PAX2. The Binding column indicates whether any binding evidence exists for this TF–gene pair (ChIP-seq or motif footprint peaks). The Mean coef is the average Perturb-seq regression coefficient across active gRNAs (positive = PAX2 upregulated upon KD; negative = downregulated). The Outlier column indicates whether this gene is in the top or bottom 5% of all TF knockdown effects.

Data: Effect:
TF Mean coef Binding Outlier TF→Gene link

Elements linked to PAX2

Open chromatin peaks (ATAC-seq) in the genomic neighbourhood of PAX2, linked by TSS proximity or chromatin conformation (Multiome / HiCAR). Each element overlaps at least one TF ChIP-seq binding site — the TFs column shows how many distinct TFs bind that element.

Accessibility Element Dist. to TSS Link type TFs
chr10:100,739,174–100,740,373 5.2 kb Proximal (<10kb) 205
chr10:100,741,019–100,741,214 4.4 kb Proximal (<10kb) 46
chr10:100,741,435–100,742,741 2.8 kb Proximal (<10kb) 105
chr10:100,743,670–100,744,309 1.3 kb Proximal (<10kb) 280
chr10:100,744,447–100,746,357 at TSS At TSS 379
chr10:100,747,830–100,748,384 2.2 kb Proximal (<10kb) 89

Genome Browser

Genomic view of the PAX2 locus showing ATAC-seq accessibility and RNA-seq expression across the ESC → DE time course, together with TF binding peaks and element-to-TSS loop connections.

chr10:100,729,174 – 100,758,384
Proximal 1 kb Distal 10 kb Multiome HiCAR ATAC-seq RNA-seq